| Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma (NCT04823741) | Hospices Civils de Lyon | 2022-02-11 |
| A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) (NCT04914897) | Sanofi | 2021-09-23 |
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
| DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma (NCT04334759) | PrECOG, LLC. | 2021-02-18 |
| Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention (NCT05910112) | University of Oxford | 2020-09-01 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S (NCT04430842) | Quadriga Biosciences, Inc. | 2020-07-20 |
| eRAPID: Online Symptom Reporting in Lung Cancer (NCT04324437) | University of Leeds | 2020-07-20 |
| A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia (NCT05077111) | Mohamed Reda Ashour | 2020-01-15 |
| From Presentation to Diagnosis: Patterns of Pleural Effusion (NCT07449624) | Mansoura University Hospital | 2020-01-01 |
| Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma (NCT04040231) | Memorial Sloan Kettering Cancer Center | 2019-07-24 |
| Mesothelioma Early Detection by VOCs (NCT04106973) | Henry Ford Health System | 2019-06-05 |
| Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma (NCT02899195) | PrECOG, LLC. | 2017-06-13 |
| Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program (NCT02585362) | Kantonsspital Winterthur KSW | 2016-03-01 |
| A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma (NCT02707666) | University of Chicago | 2016-02-25 |
| International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) (NCT03210298) | Sabine Rhode | 2016-01-01 |
| A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1) (NCT02588131) | Italian Network for Tumor Biotherapy Foundation | 2015-10-01 |
| TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients (NCT02414945) | University Health Network, Toronto | 2015-05-15 |
| Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy (NCT01160458) | National Cancer Institute (NCI) | 2010-06-02 |
| Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma (NCT00895648) | University Health Network, Toronto | 2009-01-01 |
| Trimodal Lung-Sparing Treatment of Pleural Mesothelioma (NCT00859495) | Columbia University | 2008-02-01 |
| Gene Therapy for Pleural Malignancies (NCT00299962) | University of Pennsylvania | 2006-03-01 |
| Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate (NCT00165503) | Dana-Farber Cancer Institute | 2004-04-01 |
| Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate (NCT00165516) | Dana-Farber Cancer Institute | 2004-01-01 |